RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 66 filers reported holding RA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,572,000 | -21.3% | 743,000 | 0.0% | 0.58% | -14.4% |
| Q2 2019 | $22,342,000 | +177.1% | 743,000 | +106.4% | 0.68% | +145.1% |
| Q1 2019 | $8,062,000 | +14.2% | 359,900 | -7.2% | 0.28% | -11.5% |
| Q4 2018 | $7,062,000 | +0.6% | 388,000 | 0.0% | 0.31% | +21.3% |
| Q3 2018 | $7,019,000 | +81.8% | 388,000 | 0.0% | 0.26% | +61.2% |
| Q2 2018 | $3,861,000 | +87.4% | 388,000 | 0.0% | 0.16% | +66.7% |
| Q1 2018 | $2,060,000 | +41.1% | 388,000 | +288.0% | 0.10% | +15.7% |
| Q3 2017 | $1,460,000 | -22.1% | 100,000 | 0.0% | 0.08% | -29.1% |
| Q2 2017 | $1,874,000 | – | 100,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |